Johnson & Johnson (NYSE:JNJ) reported its Q2 results on July 19th 2016, which topped analysts’ estimates, leading the stock higher where it has stabilized since. We listened in on the earnings call and here are three reasons to be modestly bullish on the stock on the back of the Q2 results conference call.
Read more at:
http://seekingalpha.com/article/3990613-johnson-and-johnson-3-reasons-optimistic-q2-results
Erick Mokaya's Blog 